Skip to main content
. 2021 Feb 12;2021(2):CD013587. doi: 10.1002/14651858.CD013587.pub2

2.6. Analysis.

2.6

Comparison 2: CQ versus lopinavir/ritonavir for treatment, Outcome 6: Serious adverse events